Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > ACC invitation is great acknowledgment of AGN's work

View:

Post by waves1 on Aug 04, 2022 3:36pm

ACC invitation is great acknowledgment of AGN's work

AGN being invited to present the results from its Phase 2a study of NP-120 for IPF and Chronic Cough at the American Cough Conference in June 2023 is a significant acknowledgment of their work within the field.

Held every two years, the conference is the worlds leading educational meeting for health care professionals involved in the research and management of patients with coughs.

A conference chair highlighted their excitement at AGN's attendance as they believe the receptor to be a fascinating target as it would be a first-in-class treatment if successful.

https://ca.finance.yahoo.com/news/algernon-pharmaceuticals-invited-present-phase-110700114.html

100